Brittani Seynnaeve

Assistant Professor, Associate Pediatric Hematology/Oncology Fellowship Director, Pediatric Melanoma Program Director

Children's Hospital of Pittsburgh of UPMC
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Limited information is available on the clinicopathologic features and management of pediatric CRTC1::TRIM11 (CTRTs) and MED15::ATF1 ‐rearranged tumors (MARTs). In this series of pediatric CTRTs ( n = 5) and MARTs ( n = 2), all tumors exhibited spitzoid morphology and expressed melanocytic markers. Metastatic progression occurred in one CTRT and two MARTs: all three received immunotherapy, resulting in disease control in two patients and one death due to progressive disease. A fourth individual had lymph node micrometastasis that remained stable without progression. This case series highlights the potentially aggressive behavior of these tumors and suggests that immunotherapy may be an effective treatment option for advanced disease.

Year:

2025

Year:

2024

Year:

2024

Collaborators (3)

Alberto Pappo

Member

St. Jude Children's Research Hospital

UNITED STATES
View details

Michael Sargen

Lasker Clinical Research Scholar

National Cancer Institute

UNITED STATES
View details

Stephen Hewitt

Editor-in-Chief

National Cancer Institute

UNITED STATES
View details